Ketamine Korner: Edition 3
Ketamine Korner is a bi-weekly newsletter exploring advances in ketamine therapy, originally started by Mind Pain Relief Institute Co-Founder Dr. Rohit Aiyer.
Each edition is republished with permission from Dr. Aiyer.
Latest Research Highlight:
Research Update: A landmark 2025 study published in Nature Medicine explored ketamine’s potential beyond depression — specifically, its effects on post-traumatic stress disorder (PTSD). In a double-blind, placebo-controlled trial involving 200 participants, researchers found that a course of six intravenous ketamine infusions over three weeks led to a 65% reduction in core PTSD symptoms, including intrusive memories, hyperarousal, and emotional numbness. Remarkably, these improvements persisted for up to three months after treatment ended.
Researchers believe this is due to ketamine’s ability to “reset” fear circuitry in the brain, disrupting maladaptive memory pathways and promoting new, healthier neural connections. While larger studies are needed, this research signals ketamine’s expanding promise far beyond its antidepressant roots.
A Brief History of Ketamine in Trauma Treatment:
Early Interest in Trauma: While most early ketamine studies focused on depression, the drug’s ability to modulate memory and neuroplasticity quickly caught the attention of trauma researchers. By the late 2000s, small-scale studies began testing ketamine for PTSD, especially in veterans and first responders.
Breakthrough Discoveries: In 2014, a pilot study at Mount Sinai Hospital in New York showed significant reductions in PTSD symptoms after a single infusion, paving the way for larger clinical trials. Subsequent research built on these findings, emphasizing not just symptom relief but also improvements in emotional regulation and cognitive flexibility — two areas notoriously resistant to traditional therapies.
Therapeutic Integration: Today, many clinics integrate ketamine with trauma-focused psychotherapies such as EMDR (Eye Movement Desensitization and Reprocessing) or somatic experiencing, aiming to reprocess traumatic memories in a more adaptive way. This combined approach is increasingly seen as a frontier in trauma treatment.
Mythbuster:
Myth: Ketamine only treats depression and has no use for trauma or PTSD.
Reality: While ketamine’s antidepressant effects are the most widely publicized, emerging evidence shows it can also profoundly impact trauma-related disorders. By disrupting rigid neural patterns associated with traumatic memories and facilitating neuroplasticity, ketamine may help patients process and integrate trauma more effectively.
It’s not a standalone cure, but when combined with therapy and proper clinical oversight, ketamine is proving to be a powerful tool for PTSD, complex trauma, and other stress-related conditions.
Key Takeaway: Ketamine’s therapeutic potential continues to grow — from treating depression and suicidal ideation to now showing promise as a breakthrough intervention for trauma. As the science evolves, so does our understanding of how this medicine can reshape healing at the deepest levels.
As the science evolves, so does our understanding of ketamine’s place in modern psychiatry. Staying informed helps us separate fact from myth and see where the future of treatment may lead.
Until next time, stay curious and engaged with the possibilities ahead.